| Literature DB >> 33898499 |
Chelsia Gillis1, Sarah J Davies2, Francesco Carli1, Paul E Wischmeyer3, Stephen A Wootton4,5,6, Alan A Jackson4,5, Bernhard Riedel7,8,9, Luise V Marino2,5,6,10, Denny Z H Levett6,11, Malcolm A West6,11,12.
Abstract
Background: Prehabilitation aims to improve functional capacity prior to cancer treatment to achieve better psychosocial and clinical outcomes. Prehabilitation interventions vary considerably in design and delivery. In order to identify gaps in knowledge and facilitate the design of future studies, we undertook a scoping review of prehabilitation studies to map the range of work on prehabilitation being carried out in any cancer type and with a particular focus on diet or nutrition interventions.Entities:
Keywords: oncological nutrition; pre-operative; pre-surgery; prehabilitation; surgical nutrition
Year: 2021 PMID: 33898499 PMCID: PMC8062858 DOI: 10.3389/fnut.2021.644723
Source DB: PubMed Journal: Front Nutr ISSN: 2296-861X
Figure 1Flow chart of search results.
Patient, study, and intervention characteristics of all prehabilitation studies.
| Europe | 63 | 57.3 |
| Canada | 23 | 20.9 |
| United States | 15 | 13.6 |
| Asia | 4 | 3.6 |
| Australia | 5 | 4.6 |
| Primary studies | 61 | 55.5 |
| Secondary analysis | 8 | 7.3 |
| Systematic review | 16 | 14.5 |
| Meta/pooled analysis | 9 | 8.2 |
| Protocol | 13 | 11.8 |
| Implementation study/description of prehabilitation implementation | 3 | 2.7 |
| Randomized controlled trial | 23 | 37.7 |
| Cohort study | 25 | 40.9 |
| Case report | 4 | 6.6 |
| Pilot | 9 | 14.8 |
| Functional | 40 | 36.4 |
| Clinical | 25 | 22.7 |
| Patient reported | 9 | 8.2 |
| Nutrition outcome | 1 | 0.9 |
| Feasibility | 17 | 15.5 |
| Mixed primary outcomes | 3 | 2.7 |
| Not applicable/ not specified | 15 | 13.6 |
| Surgery | 103 | 93.6 |
| Definitive oncological treatment | 7 | 6.4 |
| Colorectal | 35 | 31.8 |
| Lung | 9 | 8.2 |
| Pancreatic | 4 | 3.6 |
| Bladder | 4 | 3.6 |
| Gastric | 1 | 0.9 |
| Esophageal | 4 | 3.6 |
| Breast | 4 | 3.6 |
| Prostate | 7 | 6.4 |
| Hematological | 4 | 3.6 |
| Head and neck | 2 | 1.8 |
| Brain | 1 | 0.9 |
| Gynecological | 1 | 0.9 |
| Mixed cancer cohort | 33 | 30.0 |
| Not specified | 1 | 0.9 |
| Exercise only | 48 | 43.6 |
| Nutrition only | 2 | 1.8 |
| Psychology only | 1 | 0.9 |
| Function only | 5 | 4.6 |
| Multimodal | 54 | 49.1 |
| Yes | 33 | 30.0 |
| No | 48 | 43.6 |
| Not specified | 12 | 10.9 |
| Not applicable | 17 | 15.5 |
| Yes | 17 | 51.5 |
| No | 15 | 45.5 |
| Not specified/ enough information available | 1 | 3.0 |
| Yes | 13 | 39.4 |
| No | 5 | 15.2 |
| Not specified | 15 | 45.4 |
Not applicable refers to any study that did not collect primary data.
Study and intervention characteristics of prehabilitation studies with a nutrition component.
| Randomized controlled trial | 6 | 16.2 |
| Cohort study | 11 | 29.7 |
| Case report | 1 | 2.7 |
| Pilot | 5 | 13.5 |
| Feasibility | 1 | 2.7 |
| Protocol | 10 | 27.0 |
| Implementation study/description of prehabilitation implementation | 2 | 5.4 |
| Qualitative study | 1 | 2.7 |
| Surgery | 37 | 100.0 |
| Definitive oncological treatment | 0 | 0 |
| Yes | 29 | 78.4 |
| No | 8 | 21.6 |
| Yes | 21 | 56.8 |
| No | 16 | 43.2 |
| Surgery or oncology guideline | 9 | 42.9 |
| Expert consensus | 2 | 9.5 |
| Another study referenced | 3 | 14.3 |
| No reference provided | 7 | 33.3 |
| Supplementation only | 3 | 8.1 |
| Counseling only | 3 | 8.1 |
| Counseling (generalized or personalized) in addition to supplementation | 19 | 51.3 |
| Leaflet | 2 | 5.4 |
| Ingredients provided | 1 | 2.7 |
| Not enough information provided | 9 | 24.3 |
| Protein supplements | 11 | 50.0 |
| Protein supplements in addition to vitamin and/or mineral supplementation | 3 | 13.6 |
| High energy oral nutritional supplements | 1 | 4.6 |
| Immunonutrition | 1 | 4.6 |
| Leucine | 1 | 4.6 |
| Not specified | 5 | 22.7 |
| Yes | 11 | 29.7 |
| No/not specified | 26 | 70.3 |
| Yes | 16 | 43.2 |
| No | 21 | 56.8 |